We observed that a combination treatment of genistein with the HDAC inhibitor trichostatin A (TSA) effectively enhanced the treatment efficacy of tamoxifen through reactivated ERα expression in ER-negative BC cells [237]. This evidence concerns the gene HDAC9 and breast cancer.